Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

NCT04792073

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

NCT05261399

Conditions
Carcinoma, Neoplasm Metastasis, Neoplasms, +6 more
Locations
  • Research Site Orlando, Florida, United States
  • Research Site Honolulu, Hawaii, United States
  • Research Site New Brunswick, New Jersey, United States
  • Research Site New York, United States
View all 226 locations
View Trial Details
Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions
Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Irvine Health Orange, California, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

NCT05853575

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations
  • Local Institution - 101 Santa Rosa, California, United States
  • Local Institution - 105 Kansas City, Missouri, United States
  • Local Institution - 100 Durham, North Carolina, United States
  • Local Institution - 106 Dallas, Texas, United States
View all 98 locations
View Trial Details

Related conditions